NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00821990,Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer,https://clinicaltrials.gov/study/NCT00821990,,COMPLETED,"Because well-designed, randomized, controlled clinical trials are lacking in patients with advanced gastric cancer (AGC), and because randomly allocating patients to treatments that do not accord with their preferences may influence trial validity, the investigators employed a patient preference randomized trial design to compare the efficacy of second-line chemotherapy and best supportive care.",NO,Advanced Gastric Cancer,DRUG: Chemotherapy|OTHER: Best supportive care,"Survival, 1 year after last patient entered",,,Samsung Medical Center,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,200,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,2008-08-055,2008-09,2010-09,2011-06,2009-01-14,,2012-01-20,"Samsung Medical Center, Seoul, 135 710, Korea, Republic of",
